Report Detail
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM3927433 |
- 13 April, 2023 |
- Global |
- 97 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Irritable bowel syndrome (IBS) is a common disorder that affects the large intestine. Signs and symptoms include cramping, abdominal pain, bloating, gas, and diarrhea or constipation, or both. IBS is a chronic condition that need to manage long term.
IBS that causes increased diarrhea is often called IBS-D. Diarrhea predominant irritable bowel syndrome (IBS-D) is a subtype of IBS in which a person experiences frequent episodes of diarrhea with accompanying abdominal pain. Like IBS, IBS-D is a functional gastrointestinal disorder (FGD) in that there is no visible disease, inflammation, or injury to account for its symptoms. It is estimated that approximately a third of people who have IBS experience the disorder with diarrhea as the predominant bowel habit.
In this report, we study the drugs for diarrhea predominant irritable bowel syndrome (IBS-D).
According to our (Global Info Research) latest study, the global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market size was valued at USD 1428.3 million in 2022 and is forecast to a readjusted size of USD 2826.1 million by 2029 with a CAGR of 10.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest consumption place of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs, followed by Europe. The two account for more than 80% of the consumer market in together. The most used IBS-D drug is XIFAXAN, accounting for more than 60% of the market share, followed by Viberzi and Lotronex. IBS-D drugs are widely sold through hospital pharmacies and retail pharmacies.
This report is a detailed and comprehensive analysis for global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Sales Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market size and forecasts, by Type and by Sales Channel, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bausch Health, Allergan, Sebela Pharmaceuticals, Astellas Pharmaceuticals and Amneal Pharms and etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market is split by Type and by Sales Channel. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Sales Channel in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
XIFAXAN
Viberzi
Lotronex
Other
Market segment by Sales Channel
Hospitals Pharmacy
Retail Pharmacy
Other
Major players covered
Bausch Health
Allergan
Sebela Pharmaceuticals
Astellas Pharmaceuticals
Amneal Pharms
Pharscin Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs, with price, sales, revenue and global market share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs from 2018 to 2023.
Chapter 3, the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and sales channel, with sales market share and growth rate by type, sales channel, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market forecast, by regions, type and sales channel, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs.
Chapter 14 and 15, to describe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 XIFAXAN
- 1.3.3 Viberzi
- 1.3.4 Lotronex
- 1.3.5 Other
- 1.4 Market Analysis by Sales Channel
- 1.4.1 Overview: Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value by Sales Channel: 2018 Versus 2022 Versus 2029
- 1.4.2 Hospitals Pharmacy
- 1.4.3 Retail Pharmacy
- 1.4.4 Other
- 1.5 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size & Forecast
- 1.5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity (2018-2029)
- 1.5.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 Bausch Health
- 2.1.1 Bausch Health Details
- 2.1.2 Bausch Health Major Business
- 2.1.3 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Services
- 2.1.4 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Bausch Health Recent Developments/Updates
- 2.2 Allergan
- 2.2.1 Allergan Details
- 2.2.2 Allergan Major Business
- 2.2.3 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Services
- 2.2.4 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Allergan Recent Developments/Updates
- 2.3 Sebela Pharmaceuticals
- 2.3.1 Sebela Pharmaceuticals Details
- 2.3.2 Sebela Pharmaceuticals Major Business
- 2.3.3 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Services
- 2.3.4 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Sebela Pharmaceuticals Recent Developments/Updates
- 2.4 Astellas Pharmaceuticals
- 2.4.1 Astellas Pharmaceuticals Details
- 2.4.2 Astellas Pharmaceuticals Major Business
- 2.4.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Services
- 2.4.4 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Astellas Pharmaceuticals Recent Developments/Updates
- 2.5 Amneal Pharms
- 2.5.1 Amneal Pharms Details
- 2.5.2 Amneal Pharms Major Business
- 2.5.3 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Services
- 2.5.4 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Amneal Pharms Recent Developments/Updates
- 2.6 Pharscin Pharma
- 2.6.1 Pharscin Pharma Details
- 2.6.2 Pharscin Pharma Major Business
- 2.6.3 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Services
- 2.6.4 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Pharscin Pharma Recent Developments/Updates
3 Competitive Environment: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Manufacturer
- 3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Manufacturer (2018-2023)
- 3.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturer Market Share in 2022
- 3.4.2 Top 6 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturer Market Share in 2022
- 3.5 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market: Overall Company Footprint Analysis
- 3.5.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market: Region Footprint
- 3.5.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market: Company Product Type Footprint
- 3.5.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Region
- 4.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Region (2018-2029)
- 4.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value by Region (2018-2029)
- 4.1.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price by Region (2018-2029)
- 4.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value (2018-2029)
- 4.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value (2018-2029)
- 4.4 Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value (2018-2029)
- 4.5 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value (2018-2029)
- 4.6 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Type (2018-2029)
- 5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value by Type (2018-2029)
- 5.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price by Type (2018-2029)
6 Market Segment by Sales Channel
- 6.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Sales Channel (2018-2029)
- 6.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value by Sales Channel (2018-2029)
- 6.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price by Sales Channel (2018-2029)
7 North America
- 7.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Type (2018-2029)
- 7.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Sales Channel (2018-2029)
- 7.3 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Country
- 7.3.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Country (2018-2029)
- 7.3.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Type (2018-2029)
- 8.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Sales Channel (2018-2029)
- 8.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Country
- 8.3.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Sales Channel (2018-2029)
- 9.3 Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Region
- 9.3.1 Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Type (2018-2029)
- 10.2 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Sales Channel (2018-2029)
- 10.3 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Country
- 10.3.1 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Country (2018-2029)
- 10.3.2 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Sales Channel (2018-2029)
- 11.3 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Country
- 11.3.1 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Drivers
- 12.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Restraints
- 12.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 12.5 Influence of COVID-19 and Russia-Ukraine War
- 12.5.1 Influence of COVID-19
- 12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
- 13.1 Raw Material of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
- 13.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Process
- 13.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Typical Distributors
- 14.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs. Industry analysis & Market Report on Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs is a syndicated market report, published as Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
